DESTOCK PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of DESTOCK PHARMA is 4.5% (elevated). The 2025 annual accounts show negative equity (-€1,396) and a net result of -€752. Its solvency ranks better than 5% of 22,650 sector peers (NACE 47, financial year 2025). The company has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals.
Directors
Mandate history
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Brady Mayama |
|
| VANDERVEEREN Valérie Lydia Michelle |
|
| VESTERS Titouan |
|
| BRADY Mayame |
|
| Vanderveeren Valérie |
|
Owners and capital
Owners
1 ownerOwners 1
- Sourceact 30-09-2026share not stated
Sources: the companies' annual accounts, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Capital and shareholders
- MGMC (BE 1012.265.670) 7 shares
- MGMC (BE 1012.265.670) 7 shares
- VESTERS Titouan 42 shares · 60%
- van LIDTH de JEUDE Charlotte Suzanne Marie 7 shares · 10%
- DUBOIS François Thierry Charles 10.5 · 15%
- MELARDY Sébastien 10.5 · 15%
The Belgian Official Gazette names shareholders only when an act mentions them; the share register itself is not published.
- 30-09-2026 Capital increase · 7 new shares · in cash
- 30-09-2026 Capital increase · 7 new shares · in cash
- 09-10-2025 Capital stated in the deed · 70 shares